---
figid: PMC8014362__ajtr0013-1280-f7
figtitle: Proposed signaling pathway showing Nrf2/LASS2 regulation of the progression
  of endometrial cancer and progestin response
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC8014362
filename: ajtr0013-1280-f7.jpg
figlink: pmc/articles/PMC8014362/figure/fig07/
number: F7
caption: Proposed signaling pathway showing Nrf2/LASS2 regulation of the progression
  of endometrial cancer and progestin response. There is a feedback loop between Nrf2
  signaling pathways and high levels of estrogen. Decreased Nrf2 contributes to enhanced
  progestin sensitivity, type I endometrial cancer patients with higher Nrf2 expression
  are at greater risk for disease progression.
papertitle: LASS2 mediates Nrf2-driven progestin resistance in endometrial cancer.
reftext: Bin Yang, et al. Am J Transl Res. 2021;13(3):1280-1289.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9579366
figid_alias: PMC8014362__F7
figtype: Figure
redirect_from: /figures/PMC8014362__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8014362__ajtr0013-1280-f7.html
  '@type': Dataset
  description: Proposed signaling pathway showing Nrf2/LASS2 regulation of the progression
    of endometrial cancer and progestin response. There is a feedback loop between
    Nrf2 signaling pathways and high levels of estrogen. Decreased Nrf2 contributes
    to enhanced progestin sensitivity, type I endometrial cancer patients with higher
    Nrf2 expression are at greater risk for disease progression.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Keap1
  - cnc
  - MRP
  - Mhc
  - RNaseMRP:RNA
  - Ubi-p63E
  - Ubi-p5E
  - pr
  - cer
  - GABPA
  - NFE2L2
  - KEAP1
  - ABCC1
  - MARCKSL1
  - WLS
  - CERS2
  - Metformin
  - Ceramide
---
